Back to TCRX

GEODE CAPITAL MANAGEMENT, LLC → TCRX

GEODE CAPITAL MANAGEMENT, LLC TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
10
Latest value
$36K
Q3 2026
Peak value
$853K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$853K
Q3 2025$180K
Q4 2025$458K
Q4 2025$104K
Q1 2026$515K
Q1 2026$109K
Q2 2026$467K
Q2 2026$107K
Q3 2026$154K
Q3 2026$36K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$36K115.6K——
Q3 2026$154K488.7K——
Q2 2026$107K109.0K——
Q2 2026$467K475.8K——
Q1 2026$109K107.5K——
Q1 2026$515K509.5K——
Q4 2025$104K104.0K——
Q4 2025$458K458.2K——
Q3 2025$180K99.0K——
Q3 2025$853K468.6K——

Other funds holding TCRX

Other GEODE CAPITAL MANAGEMENT, LLC positions

NVDA

NVIDIA CORP

$122B
AAPL

APPLE INC

$108.8B
NVDA

NVIDIA CORP

$105.6B
NVDA

NVIDIA CORP

$96.7B
NVDA

NVIDIA CORP

$96.6B
AAPL

APPLE INC

$93.5B
NVDA

NVIDIA CORP

$91.6B
MSFT

MICROSOFT CORP

$86B